Trastuzumab therapy and the heart: palliation at what cost?
Open Access
- 1 July 2001
- journal article
- Published by Wiley in Congestive Heart Failure
- Vol. 7 (4) , 188-190
- https://doi.org/10.1111/j.1527-5299.2001.00241.x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Response of metastatic breast cancer to trastuzumab?The Lancet, 2000
- Serum From Patients With Severe Heart Failure Downregulates eNOS and Is ProapoptoticCirculation, 1999
- Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic DiseaseJournal of Clinical Oncology, 1999
- Herceptin raises its sights beyond advanced breast cancer.JNCI Journal of the National Cancer Institute, 1998
- Neuregulins Promote Survival and Growth of Cardiac MyocytesJournal of Biological Chemistry, 1998
- Characterization of a transient outward K+ current with inward rectification in canine ventricular myocytesAmerican Journal of Physiology-Cell Physiology, 1998
- TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κBScience, 1996
- Epidermal Growth Factor Promotes a Cardiomyoblastic Phenotype in Human Fetal Cardiac MyocytesExperimental Cell Research, 1996
- Requirement for neuregulin receptor erbB2 in neural and cardiac developmentNature, 1995
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987